TABLE 3.

Patient outcomes at end of study.

ID	Duration on diet (days)	% of days ketones >0.5 mM1	Disease status	Survival status	Reason discontinued
Cohort 1 (Meals provided)
A	>120	100	Stable	Alive	Continuing diet
B	109	100	Progression	Deceased	Diet too restrictive
C	>120	100	Stable	Alive	Continuing diet
D	79	47	Progression	Deceased	Inconvenient with upcoming events
E	>120	100	Stable	Alive	Switched to modified Atkins diet after study
F	67	100	Improvement	Alive	Continuing diet
G	>120	88	Improvement	Alive	Continuing diet
H	120	85	Stable	Alive	Diet too restrictive
Cohort 2 (Meal plans only)
I	>120	N/A	Stable	Alive	Continuing Diet
J	>120	N/A	Stable	Alive	Continuing diet
K	>120	N/A	Stable	Alive	Switched to modified Atkins
L	120	N/A	Stable	Alive	Poor appetite and excess weight loss

¹Ad¹adherence is defined by percentage of days where ketone levels >0.5 mmol/dL of total number of study days with available ketone and glucose data. N/A: Missing ketone and glucose measurements for patient. Patient F continuing diet beyond data collection period.